Kuria announces that its NIH SBIR grant has received matching funds from the Arkansas Economic Development Commission. Funds will amplify the impact of the federal research dollars.

Kuria granted an SBIR award to fund IND-enabling toxicology studies for Fuchs' dystrophy.

Kuria Therapeutics Closes Initial Fundraising Round to Develop Novel Nrf2 Activator - Funds to support ongoing preclinical development...